The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Patient compliance to oral anticancer chemotherapy evaluated in breast and colorectal cancer patients receiving capecitabine: The OCTO study.
Emilie Henin
No relevant relationships to disclose
Aurelie Bourmaud
No relevant relationships to disclose
Olivier Colomban
No relevant relationships to disclose
Vérane Schwiertz
No relevant relationships to disclose
Veronique Regnier
No relevant relationships to disclose
Benoit You
No relevant relationships to disclose
Florence Ranchon
No relevant relationships to disclose
Jerome Guitton
No relevant relationships to disclose
Raymonde Maraval-Gaget
No relevant relationships to disclose
Pascal Girard
No relevant relationships to disclose
Franck Chauvin
No relevant relationships to disclose
Gilles Freyer
No relevant relationships to disclose
Michel Tod
No relevant relationships to disclose
Catherine Rioufol
No relevant relationships to disclose
Veronique N. Trillet-Lenoir
No relevant relationships to disclose